Medical Devices & Tech

NeoChord

7700 Equitable Drive, #206
Eden Prairie, MN 55344 USA
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Artificial Chordae Tendineae for Mitral Valve Repair.

Management John Seaberg, CEO; John Zentgraf, VP Research and Development; Ronald Nelson, CFO; Annette Doxon, Director Regulatory Affairs and Quality Control; Mary Pekala, Director of Operations; Sharon Iverson, Director of Regulatory Affairs.

Click here for Financial Data
Keywords: Cardiology, Cardiac, Mitral Valve Repair, Mitral Regurgitation, Heart Valve Disease, Surgery, surgical, repair, technology

Comment


Updated: Aug. 07, 2017


Description

NeoChord is a specialty medical devices company that has developed a state-of-the art technology for minimally invasive surgical heart valve repair. The company's technology enables the minimally inva......view more

Products / Services

NeoChord is commercializing a device (NeoChord DS1000) that enables the minimally invasive surgical implantation of artificial chordae tendineae, while the heart is still beating. During normal funct......view more

Technology / Differentiation

NeoChord's technology eliminates the need for a sternotomy (opening of the chest cavity via sawing of the sternum) and cardio-pulmonary bypass. This less invasive approach can provide less traumatic t...view more

Market / Customers

The market for less invasive techniques for mitral valve repair has been estimated at over $2 billion. There are 50,000 surgeries done annually and 250,000 new patients are diagnosed each year with mi......view more


Revenue / Funding

On July 7th, 2009, NeoChord completed a $4.8 ml Series A raise bringing total investment to date to $8.4ml...view more

Status

The TACT (Transapical Artificial Chordae Tendinae) clinical trial is a multi-center, nonrandomized, prospective evaluation of NeoChord DS1000. The trial is ongoing in Germany, Italy, and Lithuan...view more

RELATED COMPANIES



0000-00-00-16753